TRAVELLI, CRISTINA
TRAVELLI, CRISTINA
DIPARTIMENTO DI SCIENZE DEL FARMACO
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus
2020-01-01 Grolla, A. A.; Miggiano, R.; Marino, D. D.; Bianchi, M.; Gori, A.; Orsomando, G.; Gaudino, F.; Galli, U.; Grosso, E. D.; Mazzola, F.; Angeletti, C.; Guarneri, M.; Torretta, S.; Calabro, M.; Boumya, S.; Fan, X.; Colombo, G.; Travelli, C.; Rocchio, F.; Aronica, E.; Wohlschlegel, J. A.; Deaglio, S.; Rizzi, M.; Genazzani, A. A.; Garavaglia, S.
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors
2020-01-01 Aprile, S.; Galli, U.; Tron, G. C.; Del Grosso, E.; Travelli, C.; Grosa, G.
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents
2015-01-01 Galli, U.; Travelli, C.; Aprile, S.; Arrigoni, E.; Torretta, S.; Grosa, G.; Massarotti, A.; Sorba, G.; Canonico, P. L.; Genazzani, A. A.; Tron, G. C.
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
2020-01-01 Serafini, M.; Torre, E.; Aprile, S.; Grosso, E. D.; Gesu, A.; Griglio, A.; Colombo, G.; Travelli, C.; Paiella, S.; Adamo, A.; Orecchini, E.; Coletti, A.; Pallotta, M. T.; Ugel, S.; Massarotti, A.; Pirali, T.; Fallarini, S.
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity
2017-01-01 Travelli, C.; Aprile, S.; Rahimian, R.; Grolla, A. A.; Rogati, F.; Bertolotti, M.; Malagnino, F.; Di Paola, R.; Impellizzeri, D.; Fusco, R.; Mercalli, V.; Massarotti, A.; Stortini, G.; Terrazzino, S.; Del Grosso, E.; Fakhfouri, G.; Troiani, M. P.; Alisi, M. A.; Grosa, G.; Sorba, G.; Canonico, P. L.; Orsomando, G.; Cuzzocrea, S.; Genazzani, A. A.; Galli, U.; Tron, G. C.
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group
2019-01-01 Travelli, C.; Aprile, S.; Mattoteia, D.; Colombo, G.; Clemente, N.; Scanziani, E.; Terrazzino, S.; Alisi, M. A.; Polenzani, L.; Grosa, G.; Genazzani, A. A.; Tron, G. C.; Galli, U.
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers
2021-01-01 Masi, M.; Racchi, M.; Travelli, C.; Corsini, E.; Buoso, E.
Molecular regulations of circadian rhythm and implications for physiology and diseases
2022-01-01 Fagiani, F.; Di Marino, D.; Romagnoli, A.; Travelli, C.; Voltan, D.; Mannelli, L. D. C.; Racchi, M.; Govoni, S.; Lanni, C.
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis
2022-01-01 Lenti, Marco Vincenzo; Facciotti, Federica; Miceli, Emanuela; Vanoli, Alessandro; Fornasa, Giulia; Lahner, Edith; Spadoni, Ilaria; Giuffrida, Paolo; Arpa, Giovanni; Pasini, Alessandra; Rovedatti, Laura; Caprioli, Flavio; Travelli, Cristina; Lattanzi, Georgia; Conti, Laura; Klersy, Catherine; Vecchi, Maurizio; Paulli, Marco; Annibale, Bruno; Corazza, Gino Roberto; Rescigno, Maria; Di Sabatino, Antonio
NAMPT: A pleiotropic modulator of monocytes and macrophages
2018-01-01 Travelli, C.; Colombo, G.; Mola, S.; Genazzani, A. A.; Porta, C.
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis
2020-01-01 Colombo, G.; Clemente, N.; Zito, A.; Bracci, C.; Colombo, F. S.; Sangaletti, S.; Jachetti, E.; Ribaldone, D. G.; Caviglia, G. P.; Pastorelli, L.; De Andrea, M.; Naviglio, S.; Lucafo, M.; Stocco, G.; Grolla, A. A.; Campolo, M.; Casili, G.; Cuzzocrea, S.; Esposito, E.; Malavasi, F.; Genazzani, A. A.; Porta, C.; Travelli, C.
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
2015-01-01 Grolla, A. A.; Torretta, S.; Gnemmi, I.; Amoruso, A.; Orsomando, G.; Gatti, M.; Caldarelli, A.; Lim, D.; Penengo, L.; Brunelleschi, S.; Genazzani, A. A.; Travelli, C.
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells
2019-01-01 Travelli, C.; Consonni, F. M.; Sangaletti, S.; Storto, M.; Morlacchi, S.; Grolla, A. A.; Galli, U.; Tron, G. C.; Portararo, P.; Rimassa, L.; Pressiani, T.; Mazzone, M.; Trovato, R.; Ugel, S.; Bronte, V.; Tripodo, C.; Colombo, M. P.; Genazzani, A. A.; Sica, A.
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
2020-01-01 Masi, M.; Garattini, E.; Bolis, M.; Di Marino, D.; Maraccani, L.; Morelli, E.; Grolla, A. A.; Fagiani, F.; Corsini, E.; Travelli, C.; Govoni, S.; Racchi, M.; Buoso, E.
Prostaglandin E2 and cancer: Insight into tumor progression and immunity
2020-01-01 Finetti, F.; Travelli, C.; Ercoli, J.; Colombo, G.; Buoso, E.; Trabalzini, L.
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
2020-01-01 Galli, U.; Colombo, G.; Travelli, C.; Tron, G. C.; Genazzani, A. A.; Grolla, A. A.
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer
2020-01-01 Buoso, E.; Masi, M.; Long, A.; Chiappini, C.; Travelli, C.; Govoni, S.; Racchi, M.
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
2020-01-01 Torretta, Simone; Colombo, Giorgia; Travelli, Cristina; Boumya, Sara; Lim, Dmitry; Genazzani, Armando A; Grolla, Ambra A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus | 1-gen-2020 | Grolla, A. A.; Miggiano, R.; Marino, D. D.; Bianchi, M.; Gori, A.; Orsomando, G.; Gaudino, F.; Galli, U.; Grosso, E. D.; Mazzola, F.; Angeletti, C.; Guarneri, M.; Torretta, S.; Calabro, M.; Boumya, S.; Fan, X.; Colombo, G.; Travelli, C.; Rocchio, F.; Aronica, E.; Wohlschlegel, J. A.; Deaglio, S.; Rizzi, M.; Genazzani, A. A.; Garavaglia, S. | |
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors | 1-gen-2020 | Aprile, S.; Galli, U.; Tron, G. C.; Del Grosso, E.; Travelli, C.; Grosa, G. | |
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents | 1-gen-2015 | Galli, U.; Travelli, C.; Aprile, S.; Arrigoni, E.; Torretta, S.; Grosa, G.; Massarotti, A.; Sorba, G.; Canonico, P. L.; Genazzani, A. A.; Tron, G. C. | |
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity | 1-gen-2020 | Serafini, M.; Torre, E.; Aprile, S.; Grosso, E. D.; Gesu, A.; Griglio, A.; Colombo, G.; Travelli, C.; Paiella, S.; Adamo, A.; Orecchini, E.; Coletti, A.; Pallotta, M. T.; Ugel, S.; Massarotti, A.; Pirali, T.; Fallarini, S. | |
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity | 1-gen-2017 | Travelli, C.; Aprile, S.; Rahimian, R.; Grolla, A. A.; Rogati, F.; Bertolotti, M.; Malagnino, F.; Di Paola, R.; Impellizzeri, D.; Fusco, R.; Mercalli, V.; Massarotti, A.; Stortini, G.; Terrazzino, S.; Del Grosso, E.; Fakhfouri, G.; Troiani, M. P.; Alisi, M. A.; Grosa, G.; Sorba, G.; Canonico, P. L.; Orsomando, G.; Cuzzocrea, S.; Genazzani, A. A.; Galli, U.; Tron, G. C. | |
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group | 1-gen-2019 | Travelli, C.; Aprile, S.; Mattoteia, D.; Colombo, G.; Clemente, N.; Scanziani, E.; Terrazzino, S.; Alisi, M. A.; Polenzani, L.; Grosa, G.; Genazzani, A. A.; Tron, G. C.; Galli, U. | |
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers | 1-gen-2021 | Masi, M.; Racchi, M.; Travelli, C.; Corsini, E.; Buoso, E. | |
Molecular regulations of circadian rhythm and implications for physiology and diseases | 1-gen-2022 | Fagiani, F.; Di Marino, D.; Romagnoli, A.; Travelli, C.; Voltan, D.; Mannelli, L. D. C.; Racchi, M.; Govoni, S.; Lanni, C. | |
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis | 1-gen-2022 | Lenti, Marco Vincenzo; Facciotti, Federica; Miceli, Emanuela; Vanoli, Alessandro; Fornasa, Giulia; Lahner, Edith; Spadoni, Ilaria; Giuffrida, Paolo; Arpa, Giovanni; Pasini, Alessandra; Rovedatti, Laura; Caprioli, Flavio; Travelli, Cristina; Lattanzi, Georgia; Conti, Laura; Klersy, Catherine; Vecchi, Maurizio; Paulli, Marco; Annibale, Bruno; Corazza, Gino Roberto; Rescigno, Maria; Di Sabatino, Antonio | |
NAMPT: A pleiotropic modulator of monocytes and macrophages | 1-gen-2018 | Travelli, C.; Colombo, G.; Mola, S.; Genazzani, A. A.; Porta, C. | |
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis | 1-gen-2020 | Colombo, G.; Clemente, N.; Zito, A.; Bracci, C.; Colombo, F. S.; Sangaletti, S.; Jachetti, E.; Ribaldone, D. G.; Caviglia, G. P.; Pastorelli, L.; De Andrea, M.; Naviglio, S.; Lucafo, M.; Stocco, G.; Grolla, A. A.; Campolo, M.; Casili, G.; Cuzzocrea, S.; Esposito, E.; Malavasi, F.; Genazzani, A. A.; Porta, C.; Travelli, C. | |
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma | 1-gen-2015 | Grolla, A. A.; Torretta, S.; Gnemmi, I.; Amoruso, A.; Orsomando, G.; Gatti, M.; Caldarelli, A.; Lim, D.; Penengo, L.; Brunelleschi, S.; Genazzani, A. A.; Travelli, C. | |
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells | 1-gen-2019 | Travelli, C.; Consonni, F. M.; Sangaletti, S.; Storto, M.; Morlacchi, S.; Grolla, A. A.; Galli, U.; Tron, G. C.; Portararo, P.; Rimassa, L.; Pressiani, T.; Mazzone, M.; Trovato, R.; Ugel, S.; Bronte, V.; Tripodo, C.; Colombo, M. P.; Genazzani, A. A.; Sica, A. | |
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression | 1-gen-2020 | Masi, M.; Garattini, E.; Bolis, M.; Di Marino, D.; Maraccani, L.; Morelli, E.; Grolla, A. A.; Fagiani, F.; Corsini, E.; Travelli, C.; Govoni, S.; Racchi, M.; Buoso, E. | |
Prostaglandin E2 and cancer: Insight into tumor progression and immunity | 1-gen-2020 | Finetti, F.; Travelli, C.; Ercoli, J.; Colombo, G.; Buoso, E.; Trabalzini, L. | |
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy | 1-gen-2020 | Galli, U.; Colombo, G.; Travelli, C.; Tron, G. C.; Genazzani, A. A.; Grolla, A. A. | |
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer | 1-gen-2020 | Buoso, E.; Masi, M.; Long, A.; Chiappini, C.; Travelli, C.; Govoni, S.; Racchi, M. | |
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) | 1-gen-2020 | Torretta, Simone; Colombo, Giorgia; Travelli, Cristina; Boumya, Sara; Lim, Dmitry; Genazzani, Armando A; Grolla, Ambra A |